The 340B Community Benefits Program was created by Congress in 1992 and requires pharmaceutical manufacturers to provide outpatient drugs to eligible hospitals at significantly reduced prices. The program’s primary focus is to enable hospitals to stretch their resources and reinvest the savings into expanding services for underserved communities. 

Savings from the 340B Community Benefits Program help our Nebraska hospitals provide more comprehensive care for underserved patients. To participate, hospitals must meet certain eligibility criteria, including being designated as a nonprofit or public entity and serving a disproportionate number of low-income patients. The program is paid for with drug discounts; no state or federal tax dollars are utilized. The 340B Community Benefits Program allows urban and rural hospitals to support important community health needs.

Benefits include:
Pharmaceutical Discounts
Improved Patient Access
Community Health Impact

Without 340B savings, rural hospitals and clinics have to scale back or eliminate services. Ask your senator to support LB 168 introduced by Senator Brian Hardin, legislation that prohibits drug manufacturers and wholesalers from restricting distribution of 340B drugs to contract pharmacies.